December 3, 2013
Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook
June 26, 2013
XOMA announced that Servier has initiated a POC program on gevokizumab.
June 17, 2013
XOMA Corporation announced the initiation of a pilot study to evaluate the use of gevokizumab in acute inflammatory pyoderma ...
January 2, 2013
XOMA Corporation (XOMA) recently announced that it intends to include active non-infectious anterior scleritis in the gevokizumab ...
July 6, 2012
XOMA Corporation (XOMA) recently announced that it has initiated patient enrollment in two trials being conducted with gevokizumab. ...